The Effect of Aromatherapy Massage Applied to Hemodialysis Patients With Muscle Cramp
2 other identifiers
interventional
94
1 country
1
Brief Summary
This study is a randomized controlled and single-blind study consisting of qualitative and quantitative stages to evaluate the effect of aromatherapy massage on cramp frequency, cramp pain severity and quality of life in crampy hemodialysis (HD) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2020
CompletedFirst Submitted
Initial submission to the registry
April 21, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2022
CompletedJanuary 10, 2023
January 1, 2023
2.1 years
April 21, 2021
January 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analog Scala (VAS)
The widespread use of VAS, which has been used in the research of subjective concepts from past years to the present, has been realized after in 1969. This scale; There is a number value of "0 (no pain)" at the beginning and "10 (the most unbearable pain)" at the end. The patient marks the severity of the cramp he is experiencing at that moment, and the starting and ending points of the scale as criteria. A VAS value between 1-3 means "mild pain", between 4-6 means "moderate pain", and a value between 7-10 means "severe pain". Participants will mark the scale each time they experience a cramp.
During 1 month
Secondary Outcomes (1)
Quality of Life Index Dialysis Version - III
At the first and last meeting in 1 month
Study Arms (3)
Intervention group (Aromatherapy group)
EXPERIMENTALWith a mixture of Lavandula angustifolia, Rosmarinus officinalis L. and Origanum majorana L. essential oils, the foot and lower leg will be massaged for three sessions a week for 30 minutes in each session for four weeks.
Placebo group
EXPERIMENTALThe foot and lower leg will be massaged with baby oil for four weeks, three sessions a week, 30 minutes in each session.
Control group
NO INTERVENTIONNo application will be made in addition to standard HD treatment.
Interventions
Massage application
Eligibility Criteria
You may qualify if:
- Above 18 years old,
- Able to answer questions and communicate,
- Is conscious and does not have a mental problem,
- Speaks Turkish,
- No hearing, sight or speech impairment,
- Having HD treatment for at least six months,
- Receiving three HD treatment sessions a week,
- Dialysis with bicarbonate dialysate,
- Kt / V value\> 1.2,
- Having a constant dry weight for the last month,
- Experiencing cramps during hemodialysis sessions or at any other time and who scored at least three or more when the severity of cramp pain was evaluated with the Visual Analog Scale (VAS),
- Patients who are not allergic to the oils used for massage will be included in the study.
You may not qualify if:
- Pregnant and breastfeeding women,
- Cancer,
- Diabetic foot,
- Lower extremity amputation,
- Having neurological diseases such as epilepsy, parkinson, dementia, Alzheimer,
- Those with paraplegia,
- The lower leg is in a size that prevents the application of massage,
- had surgery in the last three months,
- Loss of sensation more than 50% due to neuropathy due to various reasons,
- Open wound in the foot and lower leg, infection, necrosis, fracture / fracture suspected, soft tissue damage, burn,
- Peripheral vascular disease,
- Deep vein thrombosis,
- Receiving treatment to prevent cramping,
- Having a severe electrolyte (such as potassium, magnesium, calcium) disorder in blood values,
- Patients using any of the complementary and integrated methods in the last month will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes University
Melikgazi, Kayseri, 38260, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serife Cetin, PhD
Kayseri University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
April 21, 2021
First Posted
May 6, 2021
Study Start
November 25, 2020
Primary Completion
December 28, 2022
Study Completion
December 28, 2022
Last Updated
January 10, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share